Financial Report
1 January - 31 December
Attributable to shareholders of PolyPeptide Group AG:
| 
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
  
| 
       kEUR  | 
    
       Share capital  | 
    
       Share premium  | 
    
       Translation reserve  | 
    
       Treasury shares  | 
    
       Other capital reserves  | 
    
       Retained earnings  | 
    
       Total  | 
  
| 
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
  
| 
       Balance as at 1 January 2022  | 
    
       302  | 
    
       212,800  | 
    
       9,285  | 
    
       -1,187  | 
    
       3,946  | 
    
       196,027  | 
    
       421,173  | 
  
| 
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
  
| 
       Result for the year  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       7,767  | 
    
       7,767  | 
  
| 
       Remeasurement gain / (loss) on defined benefit plans, net of tax  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       10,352  | 
    
       10,352  | 
  
| 
       Currency exchange differences  | 
    
       
  | 
    
       
  | 
    
       4,834  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       4,834  | 
  
| 
       Total comprehensive income  | 
    
       0  | 
    
       0  | 
    
       4,834  | 
    
       0  | 
    
       0  | 
    
       18,119  | 
    
       22,953  | 
  
| 
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
  
| 
       Purchase of own shares  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       -13,933  | 
    
       
  | 
    
       
  | 
    
       -13,933  | 
  
| 
       Dividends paid  | 
    
       
  | 
    
       -9,671  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       -9,671  | 
  
| 
       Share-based payment  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       1,155  | 
    
       
  | 
    
       1,155  | 
  
| 
       Transfer of own shares  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       1,511  | 
    
       -1,511  | 
    
       
  | 
    
       0  | 
  
| 
       Total transactions with owners  | 
    
       0  | 
    
       -9,671  | 
    
       0  | 
    
       -12,422  | 
    
       -356  | 
    
       0  | 
    
       -22,449  | 
  
| 
       Balance as at 31 December 2022  | 
    
       302  | 
    
       203,129  | 
    
       14,119  | 
    
       -13,609  | 
    
       3,590  | 
    
       214,146  | 
    
       421,677  | 
  
1 January - 31 December
Attributable to shareholders of PolyPeptide Group AG:
| 
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
  
| 
       kEUR  | 
    
       Share capital  | 
    
       Share premium  | 
    
       Translation reserve  | 
    
       Treasury shares  | 
    
       Other capital reserves  | 
    
       Retained earnings  | 
    
       Total  | 
  
| 
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
  
| 
       Balance as at 1 January 2021  | 
    
       33,000  | 
    
       2,340  | 
    
       -5,616  | 
    
       0  | 
    
       0  | 
    
       147,936  | 
    
       177,660  | 
  
| 
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
  
| 
       Result for the year  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       47,258  | 
    
       47,258  | 
  
| 
       Remeasurement gain / (loss) on defined benefit plans, net of tax  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       833  | 
    
       833  | 
  
| 
       Currency exchange differences  | 
    
       
  | 
    
       
  | 
    
       14,901  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       14,901  | 
  
| 
       Total comprehensive income  | 
    
       0  | 
    
       0  | 
    
       14,901  | 
    
       0  | 
    
       0  | 
    
       48,091  | 
    
       62,992  | 
  
| 
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
  
| 
       Business restructuring  | 
    
       -33,000  | 
    
       33,000  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       0  | 
  
| 
       Incorporation of PolyPeptide Group AG  | 
    
       273  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       273  | 
  
| 
       Issue of new shares  | 
    
       29  | 
    
       182,112  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       182,141  | 
  
| 
       IPO-related costs charged to equity  | 
    
       
  | 
    
       -4,652  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       -4,652  | 
  
| 
       Purchase of own shares  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       -5,464  | 
    
       
  | 
    
       
  | 
    
       -5,464  | 
  
| 
       Share-based payment  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       4,264  | 
    
       
  | 
    
       4,264  | 
  
| 
       Transfer of own shares  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       4,277  | 
    
       -3,316  | 
    
       
  | 
    
       961  | 
  
| 
       Repayment by Draupnir Holding B.V. related to IPO bonus  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       
  | 
    
       2,998  | 
    
       
  | 
    
       2,998  | 
  
| 
       Total transactions with owners  | 
    
       -32,698  | 
    
       210,460  | 
    
       0  | 
    
       -1,187  | 
    
       3,946  | 
    
       0  | 
    
       180,521  | 
  
| 
       Balance as at 31 December 2021  | 
    
       302  | 
    
       212,800  | 
    
       9,285  | 
    
       -1,187  | 
    
       3,946  | 
    
       196,027  | 
    
       421,173  |